Adam is an accomplished serial entrepreneur and regenerative medicine executive with expertise in business development, leadership, and new company formation. He played a large role in the rise of Regenerative Medicine Medical Devices throughout the US over the last 10 years, including the build-out and growth of the first commercial exosomes company, leading the organization to $50M in sales in under 3 years. Prior to his tenure in Regenerative Medicine, Adam led the launch of a disruptive startup in the Neuromodulation domain, successfully growing the organization at launch, going head-to-head against Medtronic, Boston Scientific, and Abbott. He has a proven ability to build and develop high-performance relationships and teams to drive a well-organized, productive biotechnology business with particular expertise in aligning disparate inventors to build out innovative and emerging technologies across Quantum Computing, Computational Biology, and Nanotechnologies focus on drug delivery. He has exceptional business acumen developed in the biotech startup environment, generating large pharma relationships, mid-size life science organizations, and technology transfer offices, which contributes to superior problem resolution. He has strong management and leadership skills, with a proven ability to motivate professionals and navigate complex organizations.